| 1 |
18566298 | Extended-release niacin alters the metabolism of plasma apolipoprotein (Apo) A-I and ApoB-containing lipoproteins. | 2008 Sep |
2 |
| 2 |
17319473 | Evaluation of efficacy and safety of fixed dose lovastatin and niacin(ER) combination in asian Indian dyslipidemic patients: a multicentric study. | 2006 |
1 |
| 3 |
12633795 | Comparison of once-daily, niacin extended-release/lovastatin with standard doses of atorvastatin and simvastatin (the ADvicor Versus Other Cholesterol-Modulating Agents Trial Evaluation [ADVOCATE]). | 2003 Mar 15 |
1 |
| 4 |
14605511 | Once-daily niacin extended release/lovastatin combination tablet has more favorable effects on lipoprotein particle size and subclass distribution than atorvastatin and simvastatin. | 2003 Fall |
1 |
| 5 |
11144997 | Reduction of LDL cholesterol in patients with primary hypercholesterolemia by SCH 48461: results of a multicenter dose-ranging study. | 2001 Jan |
1 |
| 6 |
9920144 | Randomized crossover study of gemfibrozil versus lovastatin in familial combined hyperlipidemia: additive effects of combination treatment on lipid regulation. | 1999 Jan |
1 |
| 7 |
9555954 | Three-fold effect of lovastatin treatment on low density lipoprotein metabolism in subjects with hyperlipidemia: increase in receptor activity, decrease in apoB production, and decrease in particle affinity for the receptor. Results from a novel triple-tracer approach. | 1998 Apr |
2 |
| 8 |
9807971 | Short-term efficacy and tolerability of combination therapy with lovastatin and acipimox in Chinese patients with type 2 diabetes mellitus and mixed dyslipidemia. | 1998 Oct |
2 |
| 9 |
9108785 | The role of triglyceride-rich lipoprotein families in the progression of atherosclerotic lesions as determined by sequential coronary angiography from a controlled clinical trial. | 1997 Apr |
2 |
| 10 |
9237640 | Enhanced oxidizability of ubiquinol and alpha-tocopherol during lovastatin treatment. | 1997 Jun 30 |
1 |
| 11 |
9351353 | Lovastatin decreases de novo cholesterol synthesis and LDL Apo B-100 production rates in combined-hyperlipidemic males. | 1997 Oct |
3 |
| 12 |
8628597 | Treatment of familial hypercholesterolemia in children and adolescents: effect of lovastatin. Canadian Lovastatin in Children Study Group. | 1996 May |
1 |
| 13 |
8935222 | Lovastatin lowers serum cholesterol levels in non-insulin-dependent diabetes mellitus patients without altering their insulin sensitivity. | 1996 Mar |
1 |
| 14 |
7662319 | Inhibition of hydroxymethylglutaryl coenzyme A reductase activity does not affect the secretion rate of apolipoproteins B and AI by CaCo-2 cells. | 1995 Jan-Feb |
2 |
| 15 |
7706943 | Physiologic mechanisms of action of lovastatin in nephrotic syndrome. | 1995 Jan |
3 |
| 16 |
7981178 | Effects of lovastatin on ApoA- and ApoB-containing lipoproteins. Families in a subpopulation of patients participating in the Monitored Atherosclerosis Regression Study (MARS). | 1994 Dec |
2 |
| 17 |
8214993 | Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS). | 1993 Nov 15 |
1 |
| 18 |
8399631 | Lovastatin treatment of dyslipoproteinemia in patients on continuous ambulatory peritoneal dialysis. | 1993 |
1 |
| 19 |
8487493 | The effect of lovastatin on very low-density lipoprotein apolipoprotein B production by the liver in familial combined hyperlipidaemia. | 1993 |
3 |
| 20 |
1302351 | [Influence of lovastatin on serum lipids in patients with primary hyperlipidemia phenotype IIa and IIb. I. Efficacy of lovastatin in the treatment of hyperlipoproteinemia]. | 1992 |
1 |
| 21 |
1395911 | [The effect of lovastatin in the treatment of primary hypercholesterolemia]. | 1992 Jan |
2 |
| 22 |
1940775 | Effect of apolipoprotein E polymorphism and XbaI polymorphism of apolipoprotein B on response to lovastatin treatment in familial and non-familial hypercholesterolaemia. | 1991 Nov |
1 |
| 23 |
2051734 | Effects of HMG-CoA reductase inhibitors in hypercholesterolemic patients on hemodialysis. | 1991 Apr |
1 |
| 24 |
2294737 | The effects of lovastatin in hyperlipidemic patients with the nephrotic syndrome. | 1990 Jan |
1 |
| 25 |
2351867 | Lovastatin therapy reduces low density lipoprotein apoB levels in subjects with combined hyperlipidemia by reducing the production of apoB-containing lipoproteins: implications for the pathophysiology of apoB production. | 1990 Apr |
8 |
| 26 |
2810673 | Comparison of lovastatin and gemfibrozil in normolipidemic patients with hypoalphalipoproteinemia. | 1989 Dec 8 |
1 |
| 27 |
2912427 | Effects of combined therapy with lovastatin and colestipol in heterozygous familial hypercholesterolemia. Effects on kinetics of apolipoprotein B. | 1989 Jan-Feb |
1 |
| 28 |
2917701 | Gemfibrozil alone and in combination with lovastatin for treatment of hypertriglyceridemia in NIDDM. | 1989 Mar |
1 |
| 29 |
3055923 | Treatment of dyslipidemia in non-insulin-dependent diabetes mellitus with lovastatin. | 1988 Nov 11 |
1 |
| 30 |
3056429 | Effects of lovastatin alone and in combination with cholestyramine on serum lipids and apolipoproteins in heterozygotes for familial hypercholesterolemia. | 1988 Oct |
1 |
| 31 |
3162680 | Lovastatin therapy in familial dysbetalipoproteinemia: effects on kinetics of apolipoprotein B. | 1988 Mar |
1 |
| 32 |
3422105 | Lovastatin for lowering cholesterol levels in non-insulin-dependent diabetes mellitus. | 1988 Jan 14 |
1 |
| 33 |
3113763 | New developments in lipid-lowering therapy: the role of inhibitors of hydroxymethylglutaryl-coenzyme A reductase. | 1987 Sep |
1 |
| 34 |
3680522 | Suppression of apolipoprotein B production during treatment of cholesteryl ester storage disease with lovastatin. Implications for regulation of apolipoprotein B synthesis. | 1987 Dec |
2 |
| 35 |
3515897 | Effectiveness of mevinolin on plasma lipoprotein concentrations in type II hyperlipoproteinemia. | 1986 Apr 15 |
1 |